And Refractory Multiple Myeloma
📧 Sign up to get email alerts when something new happens for And Refractory Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Isa-Pom-Dex in Elderly/Frail Subjects With RRMM [Phase 2]
A Phase 2 trial of isatuximab-pomalidomide-dexamethasone (Isa-Pom-Dex) in elderly or frail patients with relapsed/refractory multiple myelom…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: A Study of HG146 Capsule in Chinese Subjects with Relapsed and Refractory Multiple Myeloma [Phase 1]
A Phase 1 study of HG146 Capsule in Chinese subjects with relapsed and refractory multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: Study of Oral Ixazomib in Adult Participants With Relapsed and/or Refractory (RR) Multiple Myeloma [Phase 1]
Phase 1 study of oral ixazomib in adults with relapsed or refractory multiple myeloma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies [Phase 1]
A Phase 1 study of CB-5083 in lymphoid hematologic malignancies, including relapsed and refractory multiple myeloma, has been terminated.